Page last updated: 2024-08-23

amikacin and Aortic Diseases

amikacin has been researched along with Aortic Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bayer, AS; Borrelli, RL; Crowell, D; Nast, CC; Norman, DC1
Chen, Y; Duan, Y; Han, J; Li, Q; Li, X; Li, Y; Liu, L; Liu, Y; Ma, C; Miao, QR; Sun, L; Yang, X; Yu, M; Zeng, P; Zhang, R; Zhu, Y1

Other Studies

2 other study(ies) available for amikacin and Aortic Diseases

ArticleYear
Intravegetation antimicrobial distribution in aortic endocarditis analyzed by computer-generated model. Implications for treatment.
    Chest, 1990, Volume: 97, Issue:3

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Aortic Diseases; Computer Simulation; Diffusion; Drug Administration Schedule; Endocarditis, Bacterial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits

1990
Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:7

    Topics: AMP-Activated Protein Kinases; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Cholesterol, LDL; Disease Models, Animal; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Hep G2 Cells; Humans; Hypolipidemic Agents; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Oligopeptides; Phenotype; Piperidines; Plaque, Atherosclerotic; PPAR gamma; Proprotein Convertase 9; Receptors, Adiponectin; Receptors, LDL; Response Elements; RNA Interference; Signal Transduction; Sterol Regulatory Element Binding Protein 2; Transcriptional Activation; Transfection; Up-Regulation

2017